MAT for OUD Tools & Resources

Read the Guide

A collection of tools and resources for providers, staff, and patients who offer or use medication-assisted treatment (MAT) services. See the full environmental scan (PDF 0.69 MB) and resources collection (PDF 1.28 MB) in PDF format.

Title

Use

Topic

Format

Audience

Displaying 81 - 90 of 432

Chronic Care Management Services

Provides background on payable chronic care management service codes, identifies eligible practitioners and patients, and details the Medicare Physician Fee Schedule billing requirements.

Format

Report/Paper/Issue Brief

Audience

Policymakers

Medical Providers

Other Team Members

Source

Centers for Medicare & Medicaid Services

Year

2016

Chronic Pain Management Agreement

Provides a template for an agreement that describes the patient's responsibilities and commitment not to engage in certain activities.

Format

Patient Form

Audience

Medical Providers

Other Team Members

Source

Washington State Department of Corrections

Year

2014

Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants

Provides information for treating pregnant and parenting women with OUD, as well as their infants.

Format

Guide

Audience

Medical Providers

Source

Substance Abuse and Mental Health Services Administration

Year

2018

Clinical Guideline for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain

Details evidence-based clinical practice guidelines for use of chronic opioid therapy in adults with chronic noncancer pain.

Format

Guide

Audience

Medical Providers

Source

American Pain Society and American Academy of Pain Medicine

Year

2009

Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40.

Provides guidance on the use of buprenorphine among a number of topics, including physiology and pharmacology of opioids, opioid addiction, and buprenorphine treatment; screening and assessment of OUDs; protocols for buprenorphine treatment; management of special populations; and policies and procedures related to DATA 2000.

Format

Guide

Audience

Medical Providers

Source

Substance Abuse and Mental Health Services Administration

Year

2004

Clinical Institute Narcotic Assessment (CINA) Scale for Withdrawal Symptoms

Measures 11 signs and symptoms commonly seen in patients during narcotic withdrawal. This scale can help gauge the severity of the symptoms and monitor changes in clinical status over time.

Format

Instrument/Protocol

Audience

Medical Providers

Source

Peachey J, Lei H.

Year

1988

Clinical Opiate Withdrawal Scale (COWS)

Rates 11 common opiate withdrawal signs or symptoms with a clinician-administered pen-and-paper instrument. Uses the summed score of the 11 items to assess patients’ level of withdrawal and make inferences about their level of physical dependence on opioids.

Format

Instrument/Protocol

Audience

Medical Providers

Source

Wesson D, Ling W.

Year

2003

Clinical Tools (PCSS)

These clinical tools include guidanaces and forms for the implementation of medication-assisted treatment in ambulatory care settings.

Format

Guide

Instrument/Protocol

Patient Form

Audience

Medical Providers

Behavioral Health Providers

Other Team Members

Patients

Source

Providers Clinical Support System

Year

2020

Resource Type

Website

Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder: A Brief Guide

Offers guidance on the use of MAT with extended-release injectable naltrexone for the treatment of OUD. Covers assessing patients, initiating MAT, monitoring progress, and deciding when to end treatment.

Format

Guide

Audience

Medical Providers

Source

Substance Abuse and Mental Health Services Administration

Year

2015

Clinically Relevant Drug Interactions: Buprenorphine or Methadone With Other Frequently Prescribed Drugs

Provides information about the interactions of clinical significance that occur between buprenorphine or methadone and other medications.

Link

https://30qkon2g8eif8wrj03zeh041-wpengine.netdna-ssl.com/wp-content/uploads/2014/03/PCSSMAT-Clinically-Relevant-Drug-Interactions-Buprenorphine-or-Methadone-with-Other-Frequently-Prescribed-Drugs-9-24-101.pdf

Format

Report/Paper/Issue Brief

Audience

Medical Providers

Source

McCance-Katz E. (Providers Clinical Support System)

Year

2010

Adherence, Diversion, & Misuse
Adolescents
Assessing & Managing Pain
Clinical Guidelines
Co-Occurring Behavioral Health Disorders
Co-Occurring Medical Conditions
Emergency Departments
Health Information Technology & Telehealth
Intake & Induction
Medication Considerations
Organizational Readiness
Patient Engagement
Payment & Reimbursement
Pregnant/Post-Partum Women & Their Infants
Prescribing Opioids
Program Policies & Procedures
Psychosocial Supports
Regulations & Recordkeeping
Screening for Substance Use Disorders/Opioid Use Disorder
Screening, Brief Intervention, Referral to Treatment (SBIRT)
Stabilization & Maintenance
Stigma
Terminating Opioid Therapy
Withdrawal from Opioids

MAT for OUD Tools & Resources

About the Collection

Clinically Relevant Drug Interactions: Buprenorphine or Methadone With Other Frequently Prescribed Drugs